Topic List : Pain
Choice-based C-section pain management
The Stanford-led research tested an approach that allowed women to choose the level of pain management they wanted during a cesarean section.
Popular opioids fail patients on SSRIs
Patients taking antidepressants known as selective serotonin reuptake inhibitors do not respond well to hydrocodone, such as Vicodin, Stanford researchers report.
Bundle of cells produces pain aversion
Pain sensation and the emotional experience of pain are not the same, and now, in mice, scientists at Stanford have found the neurons responsible for the latter.
Physical therapy for reducing opioid use
Physical therapy within three months of a musculoskeletal pain diagnosis reduced patients’ risk of long-term opioid use by about 10 percent, according to a study by researchers at Stanford and Duke.
Dental opioids and youth addiction
In teenagers and young adults, receiving opioids from dental providers is linked with elevated risk for continued opioid use and abuse, a Stanford study has found.
Mystery of headaches, nausea
By the time she was 24, Rachel Hale was on her fourth diagnosis and had been on headache medication for years. Then she met with Ian Carroll, MD, a headache and orofacial pain specialist at Stanford.
Heroin discharges surpass opioid discharges
The findings of a new Stanford-led study suggest that illicit drugs are beginning to replace prescription opioids as the source of the national drug epidemic.
Working through pain toward success in school
With the help of an advocacy program and integrated complex care team at Lucile Packard Children’s Hospital Stanford, Hari Suresh navigated an obstacle-strewn path to scholastic success.
Darnall funded for pain management study
The Stanford pain psychologist will evaluate the effectiveness of behavioral training to help people with chronic pain reduce their use of opioids.
Source of opioids’ side effects identified
Stanford researchers said they have identified the receptors to which opioids bind to produce tolerance to the drugs and increased sensitivity to pain. They also found that a commercially available drug limited those side effects in mice.